Anumana

Executive Summary

Anumana is an AI-driven health technology company spun out from nference, specializing in ECG-AI algorithms for early detection of cardiovascular diseases. Its platform analyzes electrocardiogram data to identify subtle signals of conditions like low ejection fraction and pulmonary hypertension, enabling earlier clinical intervention. With extensive clinical data partnerships, Anumana aims to commercialize non-invasive, scalable diagnostic tools. The company is privately held, headquartered in Cambridge, MA, and was founded in 2021.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance or Breakthrough Device Designation for Lead Algorithm70% success
• Q2 2026Publication of Pivotal Clinical Study Results in Peer-Reviewed Journal60% success
• Q3 2026Strategic Partnership or Licensing Deal with Major Healthcare System50% success